BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35781255)

  • 1. Anti-breast Adenocarcinoma and Anti-urease Anti-tyrosinase Properties of 5-Pentylresorcinol as Natural Compound with Molecular Docking Studies.
    Yang X; Zhao Z; Zhao C; Li Y; El-Kott AF; Bani-Fwaz MZ
    J Oleo Sci; 2022; 71(7):1031-1038. PubMed ID: 35781255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-collagenase, Anti-elastase, Anti-urease, and Anti-cancer Potentials of Isokaempferide as Natural Compound: In vitro and in silico Study.
    Yin Q; Zhang H; Huang T; Liu B; Negm S; El-Kott AF
    J Oleo Sci; 2024; 73(2):187-199. PubMed ID: 38311409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HMG-CoA Reductase, Anti-diabetic, Anti-urease, Anti-tyrosinase and Anti-leukemia Cancer Potentials of Panicolin as a Natural Compound:In vitro and in silico Study.
    Li L; Song X; Ouyang M; El-Kott AF; Bani-Fwaz MZ; Yu Z
    J Oleo Sci; 2022; 71(10):1469-1480. PubMed ID: 36184461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jack Bean Urease Inhibitors, and Antioxidant Activity Based on Palmitic acid Derived 1-acyl-3- Arylthioureas: Synthesis, Kinetic Mechanism and Molecular Docking Studies.
    Saeed A; Ur-Rehman S; Channar PA; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
    Drug Res (Stuttg); 2017 Oct; 67(10):596-605. PubMed ID: 28672409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chalcones bearing nitrogen-containing heterocyclics as multi-targeted inhibitors: Design, synthesis, biological evaluation and molecular docking studies.
    Sıcak Y; Kekeçmuhammed H; Karaküçük-İyidoğan A; Taşkın-Tok T; Oruç-Emre EE; Öztürk M
    J Mol Recognit; 2023 Jul; 36(7):e3020. PubMed ID: 37092742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urolithin and Reduced Urolithin Derivatives as Potent Inhibitors of Tyrosinase and Melanogenesis: Importance of the 4-Substituted Resorcinol Moiety.
    Lee S; Choi H; Park Y; Jung HJ; Ullah S; Choi I; Kang D; Park C; Ryu IY; Jeong Y; Hwang Y; Hong S; Chun P; Moon HR
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cephalosporin as Potent Urease and Tyrosinase Inhibitor: Exploration through Enzyme Inhibition, Kinetic Mechanism, and Molecular Docking Studies.
    Alqahtani YS; Alyami BA; Alqarni AO; Mahnashi MH; Ali A; Javed Q; Hassan M; Ehsan M
    Biomed Res Int; 2022; 2022():1092761. PubMed ID: 35937399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tyrosinase, anti-cholinesterase and cytotoxic activities of extracts and phytochemicals from the Tunisian Citharexylum spinosum L.: Molecular docking and SAR analysis.
    Saidi I; Nimbarte VD; Schwalbe H; Waffo-Téguo P; Harrath AH; Mansour L; Alwasel S; Ben Jannet H
    Bioorg Chem; 2020 Sep; 102():104093. PubMed ID: 32717693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphenolic compounds: Synthesis, assessment of antimicrobial effect and enzymes inhibition against important medicinal enzymes with computational details.
    İmamoğlu R; Koç E; Kısa D
    Bioorg Med Chem Lett; 2022 Jun; 65():128722. PubMed ID: 35395370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of Novel Human Tyrosinase Inhibitors by Molecular Modeling, Docking and Simulation Studies.
    Hassan M; Ashraf Z; Abbas Q; Raza H; Seo SY
    Interdiscip Sci; 2018 Mar; 10(1):68-80. PubMed ID: 27098808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase.
    Mann T; Scherner C; Röhm KH; Kolbe L
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spiro-acridine inhibiting tyrosinase enzyme: Kinetic, protein-ligand interaction and molecular docking studies.
    Menezes TM; de Almeida SMV; de Moura RO; Seabra G; de Lima MDCA; Neves JL
    Int J Biol Macromol; 2019 Feb; 122():289-297. PubMed ID: 30401647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity.
    Rosa GP; Palmeira A; Resende DISP; Almeida IF; Kane-Pagès A; Barreto MC; Sousa E; Pinto MMM
    Bioorg Med Chem; 2021 Jan; 29():115873. PubMed ID: 33242700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
    Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
    Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly potent tyrosinase inhibitor, neorauflavane from Campylotropis hirtella and inhibitory mechanism with molecular docking.
    Tan X; Song YH; Park C; Lee KW; Kim JY; Kim DW; Kim KD; Lee KW; Curtis-Long MJ; Park KH
    Bioorg Med Chem; 2016 Jan; 24(2):153-9. PubMed ID: 26706112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vitro inhibitory effects of some natural compounds on tyrosinase activity and molecular docking study: Antimelanogenesis potential.
    Taslimi P
    J Biochem Mol Toxicol; 2020 Nov; 34(11):e22566. PubMed ID: 32614502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Anti-Melanogenic Compounds, (
    Choi H; Ryu IY; Choi I; Ullah S; Jung HJ; Park Y; Jeong Y; Hwang Y; Hong S; Yoon IS; Yun H; Kim MS; Yoo JW; Jung Y; Chun P; Moon HR
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
    Channar PA; Saeed A; Larik FA; Rafiq M; Ashraf Z; Jabeen F; Fattah TA
    Bioorg Med Chem; 2017 Nov; 25(21):5929-5938. PubMed ID: 28988751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency.
    Khatib S; Nerya O; Musa R; Tamir S; Peter T; Vaya J
    J Med Chem; 2007 May; 50(11):2676-81. PubMed ID: 17447749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives.
    Karakaya G; Türe A; Ercan A; Öncül S; Aytemir MD
    Bioorg Chem; 2019 Jul; 88():102950. PubMed ID: 31075740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.